Latest News about BIIB
Recent news which mentions BIIB
4 Top Stock Trades for Friday: Ethereum, NIO, BIIB, BABA
December 30, 2021
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
December 30, 2021
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
December 30, 2021
From Benzinga
Don't Panic About These 2 Stocks' Falling Prices on Thursday
December 30, 2021
From Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 30, 2021
From Benzinga
Dow, S&P 500 poised for modest rise toward new records in 2021’s penultimate session
December 30, 2021
From MarketWatch
20 Stocks Moving in Thursday's Pre-Market Session
December 30, 2021
From Benzinga
This indicator flashed warnings in 2000 and 2007 — and it’s buzzing now
December 30, 2021
From MarketWatch
5 Stocks To Watch For December 30, 2021
December 30, 2021
From Benzinga
Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials
December 27, 2021
From Benzinga
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
December 27, 2021
From Benzinga
3 Unstoppable Stocks to Buy for 2022
December 23, 2021
From Motley Fool
Eisai shares sink after Japan regulators seek more data for review of Alzheimer’s drug
December 22, 2021
Tickers
BIIB
From MarketWatch
From InvestorPlace
10 Biggest Price Target Changes For Wednesday
December 22, 2021
From Benzinga
Got $1,000? These 3 Stocks Are Still Absurdly Cheap
December 22, 2021
From Motley Fool
Biogen’s decision to halve price of Alzheimer’s drug is ‘a day late and a dollar short,’ says Raymond James
December 20, 2021
From MarketWatch
After Much Criticism, Biogen Slashes Aduhelm Price In Half
December 20, 2021
Tickers
BIIB
From Benzinga
10 Biggest Price Target Changes For Monday
December 20, 2021
From Benzinga
EMA's Committee Gives Thumbs Down To Biogen's Controversial Alzheimer's Drug, As Expected
December 17, 2021
Tickers
BIIB
From Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
